A few considerations for follow-up surveillance colonoscopy

Affiliations

¹ Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, Sichuan University, Sichuan, China; Department of Gastroenterology and Hepatology, Department of Pathology, West China Hospital, Sichuan University, Sichuan, China.
² Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Comment

Xian Zhang et al. Gastrointest Endosc. 2022 Nov.

. 2022 Nov;96(5):876-877.e1.

doi: 10.1016/j.gie.2022.05.015.

¹ Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, Sichuan University, Sichuan, China; Department of Gastroenterology and Hepatology, Department of Pathology, West China Hospital, Sichuan University, Sichuan, China.
² Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

No abstract available

Comment in

Response.
Sullivan BA, Lieberman DA. Sullivan BA, et al. Gastrointest Endosc. 2022 Nov;96(5):877-878. doi: 10.1016/j.gie.2022.07.007. Gastrointest Endosc. 2022. PMID: 36270711 No abstract available.

Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort.
Kobe EA, Sullivan BA, Qin X, Redding TS 4th, Hauser ER, Madison AN, Miller C, Efird JT, Gellad ZF, Weiss D, Sims KJ, Williams CD, Lieberman DA, Provenzale D. Kobe EA, et al. Gastrointest Endosc. 2022 Sep;96(3):553-562.e3. doi: 10.1016/j.gie.2022.04.1343. Epub 2022 May 7. Gastrointest Endosc. 2022. PMID: 35533738 Free PMC article.